Eli Peled
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eli Peled has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Alexander Katzman
Pediatric Orthopedics Unit
3 shared publications- Doron Norman
Orthopedic Department, Rambam Medical Center, Haifa, Israel
3 shared publications - Amit Mor
AposTherapy Research Group, Herzliya, Israel
2 shared publications Avi Elbaz
AposTherapy Research Group, Herzliya, Israel
2 shared publications- Ganit Segal
AposTherapy Research Group, Herzliya, Israel
2 shared publications - Mark Eidelman
Rambam Health Care Campus, Meyer’s Children Hospital
2 shared publications
Latest Publications
- 28 July 2015
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 20 (7) , 818-824
A novel self-care biomechanical treatment for obese patients with knee osteoarthritis
AimTo examine the effect of a novel biomechanical, home‐based, gait training device on gait patterns of obese individuals with knee OA.MethodsThis was a retrospective analysis of 105 (32 males, 73 females) obese (body mass index > 30 kg/m2) subjects with knee OA who completed a 12‐month program using a biomechanical gait training device and performing specified exercises. They underwent a computerized gait test to characterize spatiotemporal parameters, and completed the Western Ontario and McMaster Osteoarthritis Index (WOMAC) questionnaire and Short Form‐36 (SF‐36) Health Survey. They were then fitted with biomechanical gait training devices and began a home‐based exercise program. Gait patterns and clinical symptoms were assessed after 3 and 12 months of therapy.ResultsEach gait parameter improved significantly at 3 months and more so at 12 months (P = 0.03 overall). Gait velocity increased by 11.8% and by 16.1%, respectively. Single limb support of the more symptomatic knee increased by 2.5% and by 3.6%, respectively. There was a significant reduction in pain, stiffness and functional limitation at 3 months (P < 0.001 for each) that further improved at 12 months. Pain decreased by 34.7% and by 45.7%, respectively. Functional limitation decreased by 35.0% and by 44.7%, respectively. Both the Physical and Mental Scales of the SF‐36 increased significantly (P < 0.001) at 3 months and more so following 12 months.ConclusionsObese subjects with knee OA who complied with a home‐based exercise program using a biomechanical gait training device demonstrated a significant improvement in gait patterns and clinical symptoms after 3 months, followed by an additional improvement after 12 months.
- 28 July 2015
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 20 (7) , 818-824
A novel self-care biomechanical treatment for obese patients with knee osteoarthritis
AimTo examine the effect of a novel biomechanical, home‐based, gait training device on gait patterns of obese individuals with knee OA.MethodsThis was a retrospective analysis of 105 (32 males, 73 females) obese (body mass index > 30 kg/m2) subjects with knee OA who completed a 12‐month program using a biomechanical gait training device and performing specified exercises. They underwent a computerized gait test to characterize spatiotemporal parameters, and completed the Western Ontario and McMaster Osteoarthritis Index (WOMAC) questionnaire and Short Form‐36 (SF‐36) Health Survey. They were then fitted with biomechanical gait training devices and began a home‐based exercise program. Gait patterns and clinical symptoms were assessed after 3 and 12 months of therapy.ResultsEach gait parameter improved significantly at 3 months and more so at 12 months (P = 0.03 overall). Gait velocity increased by 11.8% and by 16.1%, respectively. Single limb support of the more symptomatic knee increased by 2.5% and by 3.6%, respectively. There was a significant reduction in pain, stiffness and functional limitation at 3 months (P < 0.001 for each) that further improved at 12 months. Pain decreased by 34.7% and by 45.7%, respectively. Functional limitation decreased by 35.0% and by 44.7%, respectively. Both the Physical and Mental Scales of the SF‐36 increased significantly (P < 0.001) at 3 months and more so following 12 months.ConclusionsObese subjects with knee OA who complied with a home‐based exercise program using a biomechanical gait training device demonstrated a significant improvement in gait patterns and clinical symptoms after 3 months, followed by an additional improvement after 12 months.
- 1 May 2014
- Vol. 16 (5) , 299-302
Effect of seasonality, weather and holidays on the incidence of proximal hip fracture.
Proximal hip fractures in the elderly are common and place a heavy burden on health resources. Researching the timing of these fractures could contribute to diverting resources towards peaks in incidence and investing in prevention at certain times. To examine the effect of seasonality, weather and Jewish holidays on hip fracture incidence in older adults. The study population comprised 2050 patients aged 65 years or more who sustained a proximal hip fracture. The computerized files of the patients were reviewed for trends in incidence by season, precipitation, minimum and maximum temperatures, day of the week, and certain Jewish festivals. Hip fractures were more likely to occur in the winter than in the summer (P < 0.0001). Factors that significantly correlated with hip fracture were the maximum daily temperature (r = -0.746, P = 0.005) followed by the minimum daily temperature (r = -0.740, P = 0.006) and precipitation (r = 0.329, P = 0.02). There were fewer fractures on Saturdays (the Sabbath) as compared to other days of the week (P = 0.045). Researching the incidence on Jewish holidays, we found an elevated incidence on Passover (P < 0.0001) and a reduced incidence on the Day of Atonement (Yom Kippui) (P = 0.013). In older people there is an elevated incidence of proximal hip fractures during the winter and on the Jewish festivals. On weekends and on the Day of Atonement the incidence of proximal hip fractures was reduced.
- 1 May 2014
- Vol. 16 (5) , 299-302
Effect of seasonality, weather and holidays on the incidence of proximal hip fracture.
Proximal hip fractures in the elderly are common and place a heavy burden on health resources. Researching the timing of these fractures could contribute to diverting resources towards peaks in incidence and investing in prevention at certain times. To examine the effect of seasonality, weather and Jewish holidays on hip fracture incidence in older adults. The study population comprised 2050 patients aged 65 years or more who sustained a proximal hip fracture. The computerized files of the patients were reviewed for trends in incidence by season, precipitation, minimum and maximum temperatures, day of the week, and certain Jewish festivals. Hip fractures were more likely to occur in the winter than in the summer (P < 0.0001). Factors that significantly correlated with hip fracture were the maximum daily temperature (r = -0.746, P = 0.005) followed by the minimum daily temperature (r = -0.740, P = 0.006) and precipitation (r = 0.329, P = 0.02). There were fewer fractures on Saturdays (the Sabbath) as compared to other days of the week (P = 0.045). Researching the incidence on Jewish holidays, we found an elevated incidence on Passover (P < 0.0001) and a reduced incidence on the Day of Atonement (Yom Kippui) (P = 0.013). In older people there is an elevated incidence of proximal hip fractures during the winter and on the Jewish festivals. On weekends and on the Day of Atonement the incidence of proximal hip fractures was reduced.
- 1 October 2011
- Vol. 150 (10) , 769-73, 815
[A new non-invasive biomechanical therapy for knee osteoarthritis improves clinical symptoms and gait patterns].
The management of knee osteoarthritis (OA) focuses on reducing the levels of pain and disability. Recently, a novel biomechanical device and treatment methodology (AposTherapy) was shown to reduce the knee adduction moment while simultaneously challenging the neuromuscular control system through perturbation. The purpose of the study was to investigate the changes in gait patterns and clinical measurements following treatment with a novel biomechanical device on patients with knee OA. A total of 745 patients with bilateral knee OA were analyzed. Patients completed a gait test, Western Ontario and McMaster Osteoarthritis Index (WOMAC) questionnaire and SF-36 Health Survey at baseline and after 12 weeks. The biomechanical device was individually calibrated to each patient. Shifting the center of pressure, through changes in the location of the biomechanical elements causes realignment and reduction in the knee adduction moment. Furthermore the configuration of the biomechanical element allows training under controlled perturbation. A significant decrease was found in WOMAC pain (28.6%) and WOMAC function (25.2%) following three months of therapy (p<0.001). A significant increase was found in the patients' physical quality of life (17.8%) and mental quality of life (11.0%) (p<0.001). Gait velocity, cadence step length, stance phase and single limb support phase improved significantly following three months of therapy (7.6%, 4%, 3.7% and 1.6%, respectively). Our results suggest an overall improvement in the gait patterns, level of pain, function and quality of life of patients with knee OA following three months of AposTherapy.
- 1 October 2011
- Vol. 150 (10) , 769-73, 815
[A new non-invasive biomechanical therapy for knee osteoarthritis improves clinical symptoms and gait patterns].
The management of knee osteoarthritis (OA) focuses on reducing the levels of pain and disability. Recently, a novel biomechanical device and treatment methodology (AposTherapy) was shown to reduce the knee adduction moment while simultaneously challenging the neuromuscular control system through perturbation. The purpose of the study was to investigate the changes in gait patterns and clinical measurements following treatment with a novel biomechanical device on patients with knee OA. A total of 745 patients with bilateral knee OA were analyzed. Patients completed a gait test, Western Ontario and McMaster Osteoarthritis Index (WOMAC) questionnaire and SF-36 Health Survey at baseline and after 12 weeks. The biomechanical device was individually calibrated to each patient. Shifting the center of pressure, through changes in the location of the biomechanical elements causes realignment and reduction in the knee adduction moment. Furthermore the configuration of the biomechanical element allows training under controlled perturbation. A significant decrease was found in WOMAC pain (28.6%) and WOMAC function (25.2%) following three months of therapy (p<0.001). A significant increase was found in the patients' physical quality of life (17.8%) and mental quality of life (11.0%) (p<0.001). Gait velocity, cadence step length, stance phase and single limb support phase improved significantly following three months of therapy (7.6%, 4%, 3.7% and 1.6%, respectively). Our results suggest an overall improvement in the gait patterns, level of pain, function and quality of life of patients with knee OA following three months of AposTherapy.
- 1 November 2009
- Published by Wolters Kluwer Health in Journal of Pediatric Orthopaedics B
- Vol. 18 (6) , 308-313
Treatment duration of developmental dysplasia of the hip: age and sonography
We retrospectively assessed babies treated according to Pavlik's method and followed up in our outpatient clinic between the years 2001 and 2005, investigating the influence of age at onset of treatment and severity of sonographic pathologies on the rates of avascular necrosis and treatment duration of 343 pathological hips in 311 neonates. No osteonecrosis was observed at the 1-year follow-up. Early detection of developmental dysplasia of the hip and early initiation of treatment using Pavlik's method are important in preventing osteonecrosis, and have high success rates. When using Pavlik's method for treating developmental dysplasia of the hip, starting treatment at 13 weeks and later increases the duration of treatment.
- 1 November 2009
- Published by Wolters Kluwer Health in Journal of Pediatric Orthopaedics B
- Vol. 18 (6) , 308-313
Treatment duration of developmental dysplasia of the hip: age and sonography
We retrospectively assessed babies treated according to Pavlik's method and followed up in our outpatient clinic between the years 2001 and 2005, investigating the influence of age at onset of treatment and severity of sonographic pathologies on the rates of avascular necrosis and treatment duration of 343 pathological hips in 311 neonates. No osteonecrosis was observed at the 1-year follow-up. Early detection of developmental dysplasia of the hip and early initiation of treatment using Pavlik's method are important in preventing osteonecrosis, and have high success rates. When using Pavlik's method for treating developmental dysplasia of the hip, starting treatment at 13 weeks and later increases the duration of treatment.
- Open Access
- 1 January 2009
- Published by Springer Nature in Indian Journal of Orthopaedics
- Vol. 43 (1) , 22-6
Alendronate preserves femoral head shape and height/length ratios in an experimental rat model: A computer-assisted analysis
- 1 January 2009
- Published by Springer Nature in Indian Journal of Orthopaedics
- Vol. 43 (1) , 22-6
Open AccessAlendronate preserves femoral head shape and height/length ratios in an experimental rat model: A computer-assisted analysis
- 20 June 2006
- Published by Springer Nature in Journal of Orthopaedics and Traumatology
- Vol. 7 (2) , 88-92
Effects of alendronate medication on the fate of the necrotic femoral head of rats with or without core decompression
After producing bilateral osteonecrosis of the femoral head, rats were medicated alendronate according to one of 6 schedules. In group 1 injection was administered one week prior to the operation of devascularization and thereafter was continued for another 42 days. In group 2, medication started on the day of the operation. The control group 3 was similarly handled except that they were given injections of physiological saline. Group 4 animals were subjected to drilling of the right femoral head and treated with alendronate a week before the operation and 42 days thereafter, while in group 5 medication begun on the day of the operation. Control group 6 was similarly handled, but received physiological saline. The furthest advanced changes occurred in groups 3 and 6 (in which an advanced stage of an osteoarthritis–like disorder were observed) followed by groups 4 and 5 (in which alterations were mild to moderate), and finally by groups 1 and 2 (in which there were but mild changes). In addition, all changes were less pronounced in the animals which had been treated with alendronate for one week prior to the operation than in those given the first dose from the operative day. These findings demonstrate that bisphosphonate medication preserves the shape of rats’ femoral heads in the early post–necrotic phase to a greater degree than in the Authors’ earlier, diverse attempts to arrest the disastrous progression of the post–necrotic remodeling towards hip osteoarthritis. The presented findings warrant the preclinical trial of bisphosphonate therapy in patients admitted for the management of osteonecrosis of the femoral head.
- 20 June 2006
- Published by Springer Nature in Journal of Orthopaedics and Traumatology
- Vol. 7 (2) , 88-92
Effects of alendronate medication on the fate of the necrotic femoral head of rats with or without core decompression
After producing bilateral osteonecrosis of the femoral head, rats were medicated alendronate according to one of 6 schedules. In group 1 injection was administered one week prior to the operation of devascularization and thereafter was continued for another 42 days. In group 2, medication started on the day of the operation. The control group 3 was similarly handled except that they were given injections of physiological saline. Group 4 animals were subjected to drilling of the right femoral head and treated with alendronate a week before the operation and 42 days thereafter, while in group 5 medication begun on the day of the operation. Control group 6 was similarly handled, but received physiological saline. The furthest advanced changes occurred in groups 3 and 6 (in which an advanced stage of an osteoarthritis–like disorder were observed) followed by groups 4 and 5 (in which alterations were mild to moderate), and finally by groups 1 and 2 (in which there were but mild changes). In addition, all changes were less pronounced in the animals which had been treated with alendronate for one week prior to the operation than in those given the first dose from the operative day. These findings demonstrate that bisphosphonate medication preserves the shape of rats’ femoral heads in the early post–necrotic phase to a greater degree than in the Authors’ earlier, diverse attempts to arrest the disastrous progression of the post–necrotic remodeling towards hip osteoarthritis. The presented findings warrant the preclinical trial of bisphosphonate therapy in patients admitted for the management of osteonecrosis of the femoral head.
- Open Access
- 5 July 2005
- Published by Springer Nature in Theoretical Biology and Medical Modelling
- Vol. 2 (1) , 24
Vasculature deprivation – induced osteonecrosis of the rat femoral head as a model for therapeutic trials
Experimental Osteonecrosis: The authors' experience with experimentally produced femoral capital osteonecrosis in rats is reviewed: incising the periosteum at the base of the neck of the femur and cutting the ligamentum teres leads to coagulation necrosis of the epiphysis. The necrotic debris is substituted by fibrous tissue concomitantly with resorption of the dead soft and hard tissues by macrophages and osteoclasts, respectively. Progressively, the formerly necrotic epiphysis is repopulated by hematopoietic-fatty tissue, and replaced by architecturally abnormal and biomechanically weak bone. The femoral heads lose their smooth-surfaced hemispherical shape in the wake of the load transfer through the hip joint such that, together with regressive changes of the joint cartilage and inflammatory-hyperplastic changes of the articular membrane, an osteoarthritis-like disorder ensues.Therapeutic Choices: Diverse therapeutic options are studied to satisfy the different opinions concerning the significance of diverse etiological and pathogenic mechanisms: 1. Exposure to hyperbaric oxygen. 2. Exposure to hyperbaric oxygen and non-weight bearing on the operated hip. 3. Medication with enoxaparin. 4. Reduction of intraosseous hypertension, putting to use a procedure aimed at core decompression, namely drilling a channel through the femoral head. 5. Medication with vascular endothelial growth factor with a view to accelerating revascularization. 6. Medication with zoledronic acid to decrease osteoclastic productivity such that the remodeling of the femoral head is slowed.Glucocorticoid-related osteonecrosisappears to be apoptosis-related, thus differing from the vessel-deprivation-induced tissue coagulation found in idiopathic osteonecrosis. The quantities of TNF-α, RANK-ligand and osteoprotegerin are raised in glucocorticoid-treated osteoblasts so that the differentiation of osteoclasts is blocked. Moreover, the osteoblasts and osteocytes of the femoral cortex mostly undergo apoptosis after a lengthy period of glucocorticoid medication.
- 5 July 2005
- Published by Springer Nature in Theoretical Biology and Medical Modelling
- Vol. 2 (1) , 24
Open AccessVasculature deprivation – induced osteonecrosis of the rat femoral head as a model for therapeutic trials
Experimental Osteonecrosis: The authors' experience with experimentally produced femoral capital osteonecrosis in rats is reviewed: incising the periosteum at the base of the neck of the femur and cutting the ligamentum teres leads to coagulation necrosis of the epiphysis. The necrotic debris is substituted by fibrous tissue concomitantly with resorption of the dead soft and hard tissues by macrophages and osteoclasts, respectively. Progressively, the formerly necrotic epiphysis is repopulated by hematopoietic-fatty tissue, and replaced by architecturally abnormal and biomechanically weak bone. The femoral heads lose their smooth-surfaced hemispherical shape in the wake of the load transfer through the hip joint such that, together with regressive changes of the joint cartilage and inflammatory-hyperplastic changes of the articular membrane, an osteoarthritis-like disorder ensues.Therapeutic Choices: Diverse therapeutic options are studied to satisfy the different opinions concerning the significance of diverse etiological and pathogenic mechanisms: 1. Exposure to hyperbaric oxygen. 2. Exposure to hyperbaric oxygen and non-weight bearing on the operated hip. 3. Medication with enoxaparin. 4. Reduction of intraosseous hypertension, putting to use a procedure aimed at core decompression, namely drilling a channel through the femoral head. 5. Medication with vascular endothelial growth factor with a view to accelerating revascularization. 6. Medication with zoledronic acid to decrease osteoclastic productivity such that the remodeling of the femoral head is slowed.Glucocorticoid-related osteonecrosisappears to be apoptosis-related, thus differing from the vessel-deprivation-induced tissue coagulation found in idiopathic osteonecrosis. The quantities of TNF-α, RANK-ligand and osteoprotegerin are raised in glucocorticoid-treated osteoblasts so that the differentiation of osteoclasts is blocked. Moreover, the osteoblasts and osteocytes of the femoral cortex mostly undergo apoptosis after a lengthy period of glucocorticoid medication.
- 1 June 2004
- Vol. 143 (6) , 404
[Practical significance of sonographic type IIa of dysplastic hip joint according to Graf's classifications].
Hip joint assessment in newborns and neonates is currently performed with ultrasonography due to the high degree of sensitivity and specificity of this technology as compared to the usual radiography. Measuring the alpha and beta angles is indicative in assessing the hip joint. The alpha angle represents the bony acetabular components and the beta angle represents the cartilaginous roof. According to Graf's classifications, type IIa is subdivided into two subgroups; type IIa- and IIa+. This study examined the need for following-up on these hip joints in newborn and neonate. The study population included the newborns and neonates born in our facility between the period 1/1/1999 to 1/4/2002. We routinely screened 10,432 newborns both clinically and ultrasonographically. This included a total of 20,862 hip joints, of which 915 were pathological according to Graf's classifications. Type IIa was diagnosed in 232 newborns and a total of 330 hip joints. The follow-up examinations were performed at 6 and 12 weeks of age, and at six months of age. Each follow-up visit included clinical and sonographic evaluation and alpha angle measuring. The incidence of type IIa was 1.6% of all hips and 36.9% of the pathological hip joints. These joints were divided into two subgroups. Group A included 254 hip joints among 156 newborns, 116 girls [74.3%] and 40 boys [25.6%]. Group A members had bilateral or unilateral type IIa hip joints. In the latter case, the other joint was type I-normal. Group B included 76 hip joints among 76 newborns, 72 girls [94.5%] and four boys [5.5%]. Group B members had one type IIa hip joint and a second more severely graded hip joint. Follow-up only was required in 88% of the type IIa hip joints and 12% were treated using Pavlik's method. Surprisingly, all the joints with unilateral type IIa hips developed into normal or type I by six months of age without treatment, independent of the alpha angle value, and the pathology on the opposite side.
- 1 June 2004
- Vol. 143 (6) , 404
[Practical significance of sonographic type IIa of dysplastic hip joint according to Graf's classifications].
Hip joint assessment in newborns and neonates is currently performed with ultrasonography due to the high degree of sensitivity and specificity of this technology as compared to the usual radiography. Measuring the alpha and beta angles is indicative in assessing the hip joint. The alpha angle represents the bony acetabular components and the beta angle represents the cartilaginous roof. According to Graf's classifications, type IIa is subdivided into two subgroups; type IIa- and IIa+. This study examined the need for following-up on these hip joints in newborn and neonate. The study population included the newborns and neonates born in our facility between the period 1/1/1999 to 1/4/2002. We routinely screened 10,432 newborns both clinically and ultrasonographically. This included a total of 20,862 hip joints, of which 915 were pathological according to Graf's classifications. Type IIa was diagnosed in 232 newborns and a total of 330 hip joints. The follow-up examinations were performed at 6 and 12 weeks of age, and at six months of age. Each follow-up visit included clinical and sonographic evaluation and alpha angle measuring. The incidence of type IIa was 1.6% of all hips and 36.9% of the pathological hip joints. These joints were divided into two subgroups. Group A included 254 hip joints among 156 newborns, 116 girls [74.3%] and 40 boys [25.6%]. Group A members had bilateral or unilateral type IIa hip joints. In the latter case, the other joint was type I-normal. Group B included 76 hip joints among 76 newborns, 72 girls [94.5%] and four boys [5.5%]. Group B members had one type IIa hip joint and a second more severely graded hip joint. Follow-up only was required in 88% of the type IIa hip joints and 12% were treated using Pavlik's method. Surprisingly, all the joints with unilateral type IIa hips developed into normal or type I by six months of age without treatment, independent of the alpha angle value, and the pathology on the opposite side.
- 1 April 2003
- Vol. 142 (4) , 293-6, 316
[Method not stirrups--treating DDH according to Pavlik].
Developmental dysplasia of the hip (DDH), previously termed "congenital dislocation of the hip" (CDH), encompasses a group of related pediatric disorders, some diagnosed soon after birth or later. These include clinical instability of the hip, with or without anatomical dysplasia, subluxation or dislocation. These days, such disorders are usually diagnosed soon after birth, and can develop to normal or worsen to severe disability in time. Most of the hips are not dislocated but all pathological hips show some degree of dysplasia and a minority is dislocated. The keystone to successful treatment of DDH is early diagnosis. Screening is successful only if followed by correct early treatment. Various methods and devices have been proposed for the treatment of DDH. After closed reduction of the hip is done, sometimes with violence, rigid fixation might cause avascular necrosis of the femoral head (AVN). These methods are used less and less, having been replaced by Pavliks method, whereby, if strictly used, the AVN rates are almost zero.
- 1 April 2003
- Vol. 142 (4) , 293-6, 316
[Method not stirrups--treating DDH according to Pavlik].
Developmental dysplasia of the hip (DDH), previously termed "congenital dislocation of the hip" (CDH), encompasses a group of related pediatric disorders, some diagnosed soon after birth or later. These include clinical instability of the hip, with or without anatomical dysplasia, subluxation or dislocation. These days, such disorders are usually diagnosed soon after birth, and can develop to normal or worsen to severe disability in time. Most of the hips are not dislocated but all pathological hips show some degree of dysplasia and a minority is dislocated. The keystone to successful treatment of DDH is early diagnosis. Screening is successful only if followed by correct early treatment. Various methods and devices have been proposed for the treatment of DDH. After closed reduction of the hip is done, sometimes with violence, rigid fixation might cause avascular necrosis of the femoral head (AVN). These methods are used less and less, having been replaced by Pavliks method, whereby, if strictly used, the AVN rates are almost zero.